A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc

Vladimir Vinokur; Eduard Berenshtein; Mordechai Chevion; Dror Chevion

doi:10.4093/dmj.2024.0124

Articles

Page Path: HOME > Diabetes Metab J > Volume 48(2); 2024 > Article

Retraction Notice A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc: Vladimir Vinokur^1,2, Eduard Berenshtein¹, Mordechai Chevion¹, Dror Chevion²; Diabetes & Metabolism Journal 2024;48(2):325-325.
DOI: https://doi.org/10.4093/dmj.2024.0124
Published online: March 18, 2024

506 Views
26 Download

¹Department of Biochemistry and Molecular Biology, Institute of Medical Research Israel-Canada, The Hebrew University of Jerusalem (HUJI), Jerusalem, Israel

²Concenter Biopharma, Jerusalem, Israel

Corresponding author: Dror Chevion

Concenter Biopharma, 18 Ha-Yahalom, Tel Mond 4061818, Jerusalem, Israel E-mail: dror@concenterbiopharma.com

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Full Article

Download PDF

This retracted the article "A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc" on page 59.

Retraction to: Diabetes Metab J https://doi.org/10.4093/dmj.2022.0292

We have decided to retract the paper titled “A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc” (Diabetes Metab J 2024;48(1):59-71) by Vinokur V, Berenshtein E, Chevion M, Chevion D. It has come to our attention that the first author submitted the copyright transfer agreement form for this paper without obtaining consent from the co-authors, which is a breach of the Diabetes Metabolism Journal’s copyright policy.

According to the journal’s instructions to authors, Section 3. EDITORIAL POLICY 3.1. Copyright requires every author to sign the authorship responsibility and copyright transfer agreement form, confirming their compliance with the authorship criteria.

After a thorough discussion by the Diabetes Metabolism Journal Ethics Committee, it has been unanimously agreed to retract the paper.

Figure & Data

References

Citations

Citations to this article as recorded by

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

A New Concept in Antidiabetic Therapeutics: A Concerted Removal of Labile Iron and Intracellular Deposition of Zinc

Diabetes Metab J. 2024;48(2):325-325. Published online March 18, 2024

DOI: https://doi.org/10.4093/dmj.2024.0124

XML Download

Related articles